US 12,467,066 B2
Compositions and methods for treating retinal disorders
Robin Ali, London (GB); Takaaki Matsuki, London (GB); Alexander Smith, London (GB); and Anastasios Georgiadis, London (GB)
Assigned to UCL BUSINESS LTD, London (GB)
Filed by UCL BUSINESS LTD, London (GB)
Filed on Jun. 16, 2023, as Appl. No. 18/336,409.
Application 18/336,409 is a continuation of application No. 16/961,857, granted, now 11,680,276, previously published as PCT/GB2019/050092, filed on Jan. 14, 2019.
Claims priority of application No. 1800546 (GB), filed on Jan. 12, 2018.
Prior Publication US 2024/0067989 A1, Feb. 29, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07H 21/02 (2006.01); A61K 35/761 (2015.01); A61K 39/235 (2006.01); A61P 27/02 (2006.01); C12N 15/861 (2006.01)
CPC C12N 15/861 (2013.01) [A61K 35/761 (2013.01); A61K 39/235 (2013.01); A61P 27/02 (2018.01)] 29 Claims
OG exemplary drawing
 
1. A transcriptional control unit (TCU) of up to 2500 nucleotides in length comprising in a 5′ to 3′ direction:
(a) a Locus Control Region (LCR) comprising SEQ ID NO: 1, and
(b) a promoter element comprising SEQ ID NO: 3.